Use of Bayesian approaches in oncology clinical trials: A cross-sectional analysis
The uptake of Bayesian methods in oncology clinical trials has flattened and is still scarce, and is mostly applied to the analysis of treatment efficacy in single-arm trials with binary endpoints. There is room for further uptake and use of their potential advantages in settings with small populations and severe conditions with unmet needs.
Authors
- Ferràn Torres (ORCID: https://orcid.org/0000-0002-7355-7913)
- Caridad Pontes (ORCID: https://orcid.org/0000-0002-3274-6048)
- Gerard Carot-Sans (ORCID: https://orcid.org/0000-0001-5982-7975)
- Dan Ouchi (ORCID: https://orcid.org/0000-0002-8630-152X)
- Borja G. Lopez-Rey
Institutions
- Universitat Autònoma de Barcelona (ES)
- Hospital de Sant Pau (ES)
- Catalan Society of Family and Community Medicine (ES)
- Agencia Española de Medicamentos y Productos Sanitarios (ES)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-03-25
- DOI
- https://doi.org/10.3389/fphar.2025.1548997
- Citations
- 1
- Primary Topic
- Statistical Methods in Clinical Trials
- Type
- article
- Field-Weighted Citation Impact
- 2.63